HYTERA
9.6.2020 03:02:05 CEST | Business Wire | Press release
Imagine one day you get a traffic ticket from the police officers with the penalty amount stating: "Stay Home". Recently, movement restriction rules are being enforced in every Emirate in the UAE. In Abu Dhabi, the police officers patrol the streets round the clock and stress the need for people to stay home. They also urge the community to practice social distancing measures and to wear masks and gloves, when stepping out. The effect and efficiency of their work is being guaranteed by Hytera’s Narrowband & Broadband Convergent Communication Solution.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200608005013/en/
“During the day, we spread awareness that people should not step out during Sanitization Program and if we spot anyone not wearing a mask, we tell them to put it on. We would give a warning to first-time offenders and impose a Dh 1,000 fine if they're found outside again,” said one of the police officers from the patrols unit. Abu Dhabi Police is responsible for enforcing the compliance with the UAE federal law.
To prevent the spread of Coronavirus, police officers bear an important responsibility for ensuring the public's commitment to the national movement restrictions. The availability of reliable communication services has become an indispensable part to better safeguard citizens both in times of crisis and in normal day-to-day operations.
Abu Dhabi Police have adopted Hytera Narrowband & Broadband Convergent Communication Solution in 2019. Patrol vehicles were equipped with the Hytera Smart devices which support 2G/3G/4G and LTE. This provided the police officers with a converged radio and a smartphone supporting both narrowband and broadband technologies. Smart devices deliver key voice services through the built-in TETRA module, thereby guaranteeing the reliability and security of the Abu Dhabi Police’s daily voice communications. The LTE and Wi-Fi part of the radio provide the broadband data services and application software to support multimedia services, and smart applications used by the Police Enforcement to execute different tasks online, transmit data to the data center and send the required message or safety instructions to the public.
The built-in GPS location functionality of Hytera Smart Devices combined with integrated mapping systems and compasses can upload GPS locations to the Command and Control Center which makes the dispatch task more efficient.
“It is certainly a challenging time for everyone as the pandemic brings significant impact on our life. Many of our users like police and healthcare providers are in the front line of fighting against the virus. As a manufacturer, we believe the secure and reliable communications can make their work more efficient and effective. And as citizens, we all need to practice social distancing to minimize the risk of COVID-19 spreading in the community,” said Stanley Song, Director of the Middle East and North Africa region for Hytera.
For more information, please visit: https://bit.ly/36XU5Dz
View source version on businesswire.com: https://www.businesswire.com/news/home/20200608005013/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi®/Minjuvi®) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 14:00:00 CEST | Press release
The Phase 3 frontMIND study evaluated tafasitamab (Monjuvi®/Minjuvi®) and lenalidomide in addition to R-CHOP, the current standard of care, compared with R-CHOP alone in patients with previously untreated high-risk diffuse large B-cell lymphoma (DLBCL) and high-grade B-cell lymphoma (HGBL)Positive trends toward progression-free survival (PFS) benefit with tafasitamab and lenalidomide plus R-CHOP (Tafa-Len-R-CHOP) were observed acrossprespecified subgroups, including in patients with centrally confirmed lymphoma subtypes and both cell-of-origin (COO) molecular subtypesThe frontMIND data support the submission of global regulatory applications for tafasitamab and lenalidomide added to R-CHOP for previously untreated DLBCLThe data are being presented in an oral session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and simultaneously published in The Lancet* Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating t
Fortegra Completes Acquisition by DB Insurance29.5.2026 22:30:00 CEST | Press release
The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a
SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 22:01:00 CEST | Press release
Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
